ClinicalTrials.Veeva

Menu

Epigenetic Biomarkers for Alzheimer's Disease

The Chinese University of Hong Kong logo

The Chinese University of Hong Kong

Status

Completed

Conditions

Alzheimer Disease

Study type

Observational

Funder types

Other

Identifiers

NCT04081285
2018.441

Details and patient eligibility

About

Alzheimer's disease (AD) is a neurodegenerative disorder with no know cure. The pathogenesis of late onset AD (LOAD) is complex and multifactorial in nature, with multiple susceptibility genes and environmental factors at interplay.

The objective of this study is to improve our understanding of the risk factors of LOAD by conducting an epigenome wide study within patients of LOAD contrasted against their cognitively normal siblings.

Enrollment

250 patients

Sex

All

Ages

50+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Sufficient Cantonese competency for cognitive test
  • Written informed consent given
  • Have at least one gender-matched cognitively normal sibling

Exclusion criteria

  • Subjects who refuse blood taking procedure
  • Do not have a reliable family/caregiver informant (personal contact at least once a month)

Trial contacts and locations

1

Loading...

Central trial contact

Timothy Kwok, MD; Joanna Cheng

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems